Recent News for OPTN - OptiNose, Inc.

Date Title
Jun 30 Optinose launches development of COVID-19 prophylactic treatment
Jun 30 Optinose Announces Anti-COVID-19 Product Candidate
Jun 22 Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Jun 19 Optinose Named a 2020 Best Place to Work by Philadelphia Business Journal
May 27 Optinose to Host its Annual Meeting of Stockholders in Virtual Format
May 26 Optinose to Present at the 2020 Jefferies Virtual Healthcare Conference
May 14 Optinose to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
May 10 OptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2020 Results - Earnings Call Transcript
May 8 OptiNose, Inc. (OPTN) Q1 2020 Earnings Call Transcript
May 8 OptiNose, Inc. 2020 Q1 - Results - Earnings Call Presentation
May 7 OptiNose EPS beats by $0.03, misses on revenue
May 7 Optinose Reports First Quarter 2020 Financial Results and Operational Updates
May 3 The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Apr 30 Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020
Apr 29 Analyst Forecasts Just Got A Whole Lot More Bearish On OptiNose, Inc. (NASDAQ:OPTN)
Apr 26 Some public companies give back small biz stimulus money, others keep it
Apr 23 Treasury urges publicly traded companies to return PPP loans
Apr 21 Publicly-traded companies raided the PPP pantry
Apr 11 Does OptiNose, Inc. (NASDAQ:OPTN) Have A High Beta?
Mar 20 The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Mar 19 The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Mar 16 Moving Average Crossover Alert: OptiNose
Mar 5 Optinose, Inc. (OPTN) CEO Peter Miller on Q4 2019 Results - Earnings Call Transcript
Mar 5 OptiNose, Inc. 2019 Q4 - Results - Earnings Call Presentation
Mar 5 The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19

Back to the Main OPTN Page...